Retail group Future has exited India-based financial firm First Capital, two years after divesting much of its stake to Warburg Pincus.
The pharmaeutical companies will form a new entity call Assembly Biosciences, which will aim to produce a treatment for hepatitis B.
The metabolic disease-focused pharmaceutical company is set to target $69m when it goes public.
The corporate venturing subsidiaries of Google, Comcast and Qualcomm all exited from Divide after it was purchased by Google for an undisclosed amount.
The Take-Two backed social video platform is set to be bought in a deal that would top the $1bn mark.
The personal camera maker, backed by Foxconn and Disney, is looking to raise up to $100m in its initial public offering.
The automotive pricing data company previously raised $425m from backers including USAA, Capital One and Dealertrack.
Waze is a social navigation application software company backed by Qualcomm Ventures, the corporate venturing unit of the US-based semiconductor company.
The Novo-backed company, which is developing a treatment for hyperkalemia, will use the proceeds to support its clinical programme.
The chip maker, backed by both Qualcomm and semiconductor manufacturer Marvell, could be the subject of a $300m bid.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
